Adage Capital Partners
YARW

Adage Capital Partners’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Adage Capital Partners’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,883
Closed -$1.06M – 984
2025
Q2 		$1.06M Buy
12,883
+6,000
+87% +$390K ﹤0.01% 790
2025
Q1 		$544K Buy
6,883
+3,800
+123% +$468K ﹤0.01% 811
2024
Q4 		$516K Buy
+3,083
New +$403K ﹤0.01% 838

Other funds holding YARW

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Adage Capital Partners's YARW Position: Q3 2025 in Review

Adage Capital Partners sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2025, closing a stake of 12,883 shares — an estimated $1.06M sold.

Adage Capital Partners first reported a position in YARW in Q4 2024 and held it in 3 quarters. The position peaked at $1.06M in Q2 2025. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

  • Adage Capital Partners reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Adage Capital Partners sold 12,883 Yarrow Bioscience, Inc. Common Stock shares in Q3 2025, an estimated $1.06M.
  • Adage Capital Partners first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2024 and held it in 3 quarters.
  • Adage Capital Partners's Yarrow Bioscience, Inc. Common Stock position peaked at $1.06M in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2025.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.